Mouth cancer
A study in blood cancer patients to check the effect of two oral drugs in maintaining the status of the patient disease free. The medicines that will be given are azacytidine and pomalidomide.
Who can joinAdults
Age18+ years
Kind of studyPhase 1: first tests of safety
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 13 Oct 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalMumbaiDirections ↗
Registry summary (technical)
A Phase I study of maintenance therapy with combination of pomalidomide and oral azacytidine for adult patients with Acute Myeloid Leukaemia (AML). - Nil
Sponsor: Tata Memorial Centre
CTRI/2023/09/057552 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 13 Oct 2025 · read by us 5 Nov 2026